Status:
UNKNOWN
Efficacy of Variable Lidocaine Concentrations in Tumescent Anesthesia for Pain Control During and After Endovenous Laser Procedure; Non-inferiority Trial
Lead Sponsor:
Midwest Vein Center
Conditions:
Pain During and After Endovenous Laser Obliteration of Large Saphenous Vein Based on Lidocaine Tumescent Concentration
Eligibility:
All Genders
16-85 years
Phase:
NA
Brief Summary
Endovenous laser treatment is a minimally invasive procedure that has been shown to be a safe and effective treatment for varicose veins. Essential to the successful ablation of refluxing veins by end...
Eligibility Criteria
Inclusion
- Large Saphenous Vein treatment
- 16-85 years old, good health
- Able to understand informed consent
- Eligible for EVLT determined by physician
Exclusion
- Patients with know lidocaine sensitivity
- Bleeding disorders
- Pregnancy
- Congestive heart failure
- Liver dysfunction
- Patient ineligible for EVLT
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT02192411
Start Date
July 1 2014
Last Update
July 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Midwest Vein Center
Chicago, Illinois, United States, 60611